Correlation Between Akari Therapeutics and First Wave
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and First Wave at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and First Wave into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and First Wave BioPharma, you can compare the effects of market volatilities on Akari Therapeutics and First Wave and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of First Wave. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and First Wave.
Diversification Opportunities for Akari Therapeutics and First Wave
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Akari and First is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and First Wave BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Wave BioPharma and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with First Wave. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Wave BioPharma has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and First Wave go up and down completely randomly.
Pair Corralation between Akari Therapeutics and First Wave
If you would invest 61.00 in First Wave BioPharma on August 28, 2024 and sell it today you would earn a total of 0.00 from holding First Wave BioPharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 4.55% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. First Wave BioPharma
Performance |
| Timeline |
| Akari Therapeutics PLC |
| First Wave BioPharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akari Therapeutics and First Wave Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and First Wave
The main advantage of trading using opposite Akari Therapeutics and First Wave positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, First Wave can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Wave will offset losses from the drop in First Wave's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| First Wave vs. Quoin Pharmaceuticals Ltd | First Wave vs. Revelation Biosciences | First Wave vs. Dermata Therapeutics | First Wave vs. LMF Acquisition Opportunities |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |